042 – Biotech M&As accelerate. IMMU’s ADC shakes up breast cancer!

Today, I cover the latest in biotech with a highlight on Immunomedics and their antibody-drug conjugates for breast cancer.

*this is not investment advice*
http://www.breakingbiotech.com
@matthewlepoire

 

Leave a Reply

%d bloggers like this: